Results 101 to 110 of about 1,617 (165)

Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis. [PDF]

Lancet Reg Health Am
Sauré D, Zgheib A, Torres JP, Goic M, Thraves C, Pacheco J, Burgos J, Del Solar F, Neira I, O'Ryan M, Basso LJ.   +10 more
europepmc   +1 more source

Broadly neutralizing nanobodies target a defined structural pivot site on the RSV fusion protein. [PDF]

EMBO Mol Med
Wang Q, Ke X, Li E, Hong D, Cheng Z, Li H, Zhang J, Jin T, Gong R, Shu B, Chiu S.   +10 more
europepmc   +1 more source

Understanding real-world effectiveness of nirsevimab and the characteristics of breakthrough RSV infections: a study protocol of individual-participant-level data meta-analysis (the GEMINI study). [PDF]

BMJ Open Respir Res
Ren S, Zhang H, Deng S, Nair H, Li Y.
europepmc   +1 more source

Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab: A FAERS Observational Study. [PDF]

Kans J Med
Touffaha I, Ablah E, Okut H, Homan G.
europepmc   +1 more source

Knowledge, attitudes, and practices of pediatricians in Crete, Greece, regarding RSV immunization: a cross-sectional study. [PDF]

Eur J Pediatr
Vrentzos D, Pavlopoulou I, Syrogiannopoulos GA, Grivea I, Ladomenou F.   +4 more
europepmc   +1 more source

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention.

JAMA Netw Open
Boracchini R, Canova B, Cesarini M, De Marchi I, Brigadoi G, Barbieri E, Donà D, Giaquinto C, Baraldi E, Cantarutti A.   +9 more
europepmc   +1 more source

In response to the article «Reluctance of parents to immunize their children with nirsevimab»

Anales de Pediatría (English Edition)
David, Andina Martínez, Esther, Fernández Mozo, Rocio, Trincado Lamuño, Jose Antonio, Alonso-Cadenas   +3 more
openaire   +2 more sources

Infant Respiratory Syncytial Virus Immunization Through Maternal Vaccination and Nirsevimab. [PDF]

JAMA Netw Open
Acker KP, Strobino K, DeAngelis JM, Staniczenko AP, Son M, Riley LE, Han JY, Abramson EL, Grinspan ZM, Levine DA.   +9 more
europepmc   +1 more source

Determinants of success and failure of antibody-based strategies against respiratory viruses: insights from RSV and SARS-CoV-2. [PDF]

Front Immunol
Guo H, Wang H, Wu S, Lin H, Wang G, Pu Q.   +5 more
europepmc   +1 more source